Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer

This publication has 38 references indexed in Scilit:

• LHRH-agonist treatment in metastatic prostate carcinoma
  European Journal of Cancer and Clinical Oncology, 1984
• 286 An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7)
  Journal of Steroid Biochemistry, 1983
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: A new biological effect
  Life Sciences, 1981
• Binding of gonadotropin releasing hormone agonist to rat ovarian granulosa cells
  Life Sciences, 1980
• Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute
  Published by Elsevier ,1980
• Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone
  Biochemical and Biophysical Research Communications, 1980
• THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOUR
  Clinical Endocrinology, 1980
• A COMPARISON OF THE EFFECTS OF CLOMIPHENE AND TAMOXIFEN TREATMENT ON THE CONCENTRATIONS OF OESTRADIOL AND PROGESTERONE IN THE PERIPHERAL PLASMA OF INFERTILE WOMEN
  Clinical Endocrinology, 1978
• Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies
  Published by Elsevier ,1977